Chemotargets

Chemotargets is a computationally-oriented biotech company focused on the discovery and development areas of small molecule pharmaceuticals and cosmeceuticals. Located in Barcelona, it was founded on March 2006 as a spin-off initiative from Dr. Mestres'​ Systems Pharmacology lab under the auspices of the Hospital del Mar Medical Research Institute (IMIM). Chemotargets's goal is to help the pharmaceutical and cosmetics industry fast-forward the process of bringing new products to market, speeding up discovery and development programs and making them more cost-efficient. To this end, Chemotargets has designed, and continues to develop, the integrative CLARITY platform, involving a broad spectrum of cutting-edge computational methodologies and analytics tools.